Not applicableStudy completedNCT02489981What this trial is testingSpecific Use-result Surveillance of Spiriva Respimat in AsthmaticsWho this might be right forAsthma Boehringer Ingelheim 359
Not applicableStudy completedNCT00503139What this trial is testingStudy Evaluating the Safety and Efficacy of Enbrel (Etanercept) in JapanWho this might be right forRheumatoid Arthritis Pfizer 684
Not applicableStudy completedNCT02976493What this trial is testingElotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 500
Not applicableStudy completedNCT02434484What this trial is testingSymbenda Post-Marketing Surveillance (PMS)Who this might be right forLymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma Eisai Korea Inc. 84
Not applicableNot Yet RecruitingNCT03969693What this trial is testingLymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern ChemoradiationWho this might be right forMediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma Chang Gung Memorial Hospital 50
Not applicableStudy completedNCT04213209What this trial is testingSpecial Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"Who this might be right forPeripheral T Cell LymphomaPediatric Hodgkin Lymphoma Takeda 95
Not applicableLooking for participantsNCT06698887What this trial is testingEvaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in KoreaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 15
Not applicableStudy completedNCT01005628What this trial is testingBortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)Who this might be right forMultiple Myeloma Janssen Korea, Ltd., Korea 1,121
Not applicableStudy completedNCT05366036What this trial is testingTecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-remitting Eisai Korea Inc. 172
Not applicableStudy completedNCT04178317What this trial is testingThe Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical PracticeWho this might be right forCancer, Chronic Lymphocytic Leukemia (CLL) AbbVie 14
Not applicableUnknownNCT03640884What this trial is testingPost-marketing Safety Surveillance of Xueshuantong-Injection : a Registry StudyWho this might be right forAdverse Drug EventAdverse Drug ReactionsAnaphylactic Reaction+1 more Zhong Wang 30,000
Testing effectiveness (Phase 2)UnknownNCT00521287What this trial is testingImpaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus InfectionWho this might be right forNeoplasms Mackay Memorial Hospital 150
Post-approval studies (Phase 4)Ended earlyNCT01134445What this trial is testingAn Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementWho this might be right forRheumatoid ArthritisOsteoarthritisPost-traumatic Arthritis+3 more DePuy International 42
Not applicableUnknownNCT05364710What this trial is testingClinical Proof-of-concept Study on Rapid Immune Modulating EffectsWho this might be right forImmune Surveillance Natural Immune Systems Inc 24
Not applicableLooking for participantsNCT07206407What this trial is testingClinical Trial on Rapid Immune Modulating EffectsWho this might be right forImmune Surveillance Natural Immune Systems Inc 24
Not applicableLooking for participantsNCT04933552What this trial is testingPost-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With MayzentWho this might be right forMultiple Sclerosis Novartis Pharmaceuticals 867
Early research (Phase 1)Study completedNCT00001006What this trial is testingAS-101 in Patients With AIDS or AIDS Related Complex (ARC)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT01142492What this trial is testingA Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)Who this might be right forRelapsing-Remitting Multiple Sclerosis Merck KGaA, Darmstadt, Germany 403
Not applicableLooking for participantsNCT05481437What this trial is testingA Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Takeda 8
Not applicableStudy completedNCT01583244What this trial is testingKorean Post-marketing Surveillance for Orencia®Who this might be right forRheumatoid Arthritis Bristol-Myers Squibb 701